32
41
Growth Score 32 in past quarter
3 pts
Heat Score 41 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
275888
Mallinckrodt Pharmaceuticals is a pharmaceutical company that provides medicines and therapies for patients.
- Paul O'Neill: SVP Quality and Operations, Specialty Brands
- Marek Honczarenko: Executive Vice President and Chief Scientific OfficerPast Role: Sun Pharmaceutical, Senior Vice president, Head of Development
About the Company
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future success, including skills in the acquisition and management of highly regulated raw materials; strong regulatory knowledge, reputation, and relationships; distinctive manufacturing and logistics skills where
vertical integration is an advantage; expertise in specialized chemistry, development, and formulation; and global commercial reach.
